The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 2, 2021

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions
Gastric Cancer
Interventions
PROCEDURE

Neoadjuvant Therapy

"Drug:~Camrelizumab 200mg,d1,Repeat every 21 days for 3 courses; Oxaliplatin 130mg/m² ,d1;S-1 40-60mg,Bid, d1-14; S-1: bsa\<1.25m2,40mg/time,twice a day;bsa1.25\~1.5m2,50mg/time,twice a day;bsa≥1.5m2,60mg/次,twice a day,d1-d14;~Procedure: Gastric cancer resection Distal gastrectomy combined with D2 lymph node dissection"

Trial Locations (1)

130000

RECRUITING

the First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER